MedTrace Logo

Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding

NCT02108756 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272

Last updated 2014-04-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and Efficacy of L- Pantoprazole sodium to treat upper gastrointestinal ulcer bleeding.

Conditions

  • Bleeding Gastric Ulcer
  • Bleeding Duodenal Ulcer

Interventions

DRUG

L-pantoprazole sodium

2 injection L-pantoprazole sodium (40mg), Bid

DRUG

Panmeilu

An injection Panmeilu (80 mg) + 1 branch placebo, Bid;

Sponsors & Collaborators

  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-04-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02108756 on ClinicalTrials.gov